Abstract
Efficacy and Safety of Selinexor-Containing Regimens in Patients with Multiple Myeloma Previously Treated with Anti-CD38 Monoclonal Antibodies (αCD38 mAb)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have